Results for tag: "Recombinant Human Erythropoietin"

Recombinant Human Erythropoietin (rHuEPO) is a type of hematological drug used to treat anemia, a condition in which the body does not produce enough red blood cells. It is a synthetic form of the hormone erythropoietin, which is naturally produced by the kidneys. rHuEPO is used to stimulate the production of red blood cells in patients with anemia due to chronic kidney disease, chemotherapy, or HIV/AIDS. It is also used to reduce the need for blood transfusions in patients with anemia due to cancer treatments. rHuEPO is available in both injectable and oral forms, and is typically administered once or twice a week. Common side effects include headache, dizziness, fatigue, and nausea. The rHuEPO market is highly competitive, with several major players. These include Amgen, Johnson & Johnson, Pfizer, Novartis, and Roche. Show Less Read more